A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...
Zantac was a popular medication used to treat heartburn, acid reflux, and related gastrointestinal issues. However, in 2019, the U.S. Food and Drug Administration (FDA) discovered that Zantac and ...
The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharma companies ...
Get detailed information on Ranitidine, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...
British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...
So why would GSK, the largest of the four major distributors of the now-recalled stomach acid drug, suddenly abandon the tried-and-true defense mantra, “millions for defense, not a penny for tribute”?
Logically Answered Why 77,000 Cancer Patients Are Suing Pfizer (& Others) Posted: November 4, 2024 | Last updated: November 4, 2024 How Zantac Went From Miracle Drug to Deadly Poison: The Shocking ...
16 clinical studies showing no link between Zantac and cancer; the US Food and Drug Administration clearing Zantac to reenter the market; and recent litigation wins by GSK, including a case in ...
This news comes after the pharmaceutical giant paid as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused ...